Organogenesis Holdings Inc. Operating Income (Loss) in USD from Q4 2015 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Organogenesis Holdings Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q4 2015 to Q3 2025.
  • Organogenesis Holdings Inc. Operating Income (Loss) for the quarter ending September 30, 2025 was $20.7M, a 232% increase year-over-year.
  • Organogenesis Holdings Inc. Operating Income (Loss) for the twelve months ending September 30, 2025 was -$8.38M, a 34.4% increase year-over-year.
  • Organogenesis Holdings Inc. annual Operating Income (Loss) for 2024 was -$1.28M, a 110% decline from 2023.
  • Organogenesis Holdings Inc. annual Operating Income (Loss) for 2023 was $12.5M, a 43.8% decline from 2022.
  • Organogenesis Holdings Inc. annual Operating Income (Loss) for 2022 was $22.3M, a 69.1% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)

Organogenesis Holdings Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$8.38M $20.7M +$14.5M +232% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 -$22.9M -$12.6M +$1.32M +9.47% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 -$24.2M -$26.7M -$22.9M -594% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 -$1.28M $10.2M +$11.5M Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 -$12.8M $6.24M -$1.81M -22.5% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 -$11M -$13.9M -$23.6M -243% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 $12.7M -$3.85M +$149K +3.72% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 $12.5M -$1.27M -$9.99M -115% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 $22.5M $8.05M +$6.27M +353% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $16.2M $9.75M -$2.19M -18.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $18.4M -$4M -$3.87M -3026% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $22.3M $8.72M -$11M -55.9% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 $33.3M $1.78M -$14.5M -89.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $47.8M $11.9M -$11.7M -49.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $59.5M -$128K -$12.7M -101% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $72.2M $19.8M -$1.48M -6.99% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $73.7M $16.3M -$6.54M -28.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $80.2M $23.6M +$25.8M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $54.4M $12.6M +$27.7M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $26.7M $21.2M +$23.4M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $3.32M $22.8M +$31.1M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$27.8M -$2.25M +$5.07M +69.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$32.8M -$15.1M -$2.96M -24.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 -$29.9M -$2.15M +$2.33M +52% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 -$32.2M -$8.27M +$1.81M +17.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$34M -$7.32M +$9.71M +57% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$43.7M -$12.1M +$7.86M +39.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$51.6M -$4.48M -$2.08M -86.5% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-18
Q3 2018 -$49.5M -$10.1M -$7.45M -285% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$42M -$17M -$19.5M -782% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$22.5M -$20M -$17M -573% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$5.49M -$2.4M -$1.1M -85% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$4.39M -$2.62M -$2.6M Jul 1, 2017 Sep 30, 2017 10-K 2019-03-18
Q2 2017 -$1.79M $2.5M +$2.5M Apr 1, 2017 Jun 30, 2017 10-K 2019-03-18
Q1 2017 -$4.28M -$2.97M -$2.96M Jan 1, 2017 Mar 31, 2017 10-K 2019-03-18
Q4 2016 -$1.33M -$1.3M -$1.27M -5060% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-14
Q3 2016 -$55.7K -$14.5K* Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$500* Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 -$15.6K* Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 -$25.2K Dec 4, 2015 Dec 31, 2015 10-K 2018-03-14

Organogenesis Holdings Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$1.28M -$13.8M -110% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 $12.5M -$9.78M -43.8% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 $22.3M -$49.9M -69.1% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 $72.2M +$45.5M +170% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $26.7M +$56.6M Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 -$29.9M +$21.7M +42.1% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$51.6M -$46.1M -838% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-16
2017 -$5.49M +$3.28M +37.4% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-09
2016 -$8.78M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.